Docking proteins

FEBS Journal

Volumn 277, Issue 21, 2010, Pages 4356-4369

  Brummer, Tilman ^a   Schmitz Peiffer, Carsten ^b   Daly, Roger J ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Dok; DOS; FRS2; Gab; IRS; Protein modules; Protein phosphorylation; SH2; Signal transduction; Tyrosine kinase

Indexed keywords

DOCKING PROTEIN; DOWNSTREAM OF TYROSINE KINASE; FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 2; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2 ASSOCIATED BINDER; INSULIN RECEPTOR SUBSTRATE; UNCLASSIFIED DRUG; GRB2 PROTEIN, HUMAN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

ACETYLATION; CELL INVASION; CELL MIGRATION; CELL TRANSFORMATION; ENZYME ACTIVATION; HUMAN; LIPID METABOLISM; MOLECULAR INTERACTION; MYRISTYLATION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CELL MEMBRANE; CLASSIFICATION; METABOLISM; REVIEW;

ANIMALS; CELL MEMBRANE; GRB2 ADAPTOR PROTEIN; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 79952111041     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07865.x     Document Type: Short Survey

References (142)

1. Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103, 211-225.
2. Fuller DM & Zhang W (2009) Regulation of lymphocyte development and activation by the LAT family of adapter proteins. Immunol Rev 232, 72-83.
3. Hunter T (1998) The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Phil Trans R Soc Lond B 353, 583-605.
4. Defilippi P, Di Stefano P & Cabodi S (2006) p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol 16, 257-263. (Pubitemid 43728873)
5. Koretzky GA, Abtahian F & Silverman MA (2006) SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond. Nat Rev Immunol 6, 67-78. (Pubitemid 43279754)
6. Gotoh N (2008) Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins. Cancer Sci 99, 1319-1325.
7. Wohrle FU, Daly RJ & Brummer T (2009) Function, regulation and pathological roles of the Gab/DOS docking proteins. Cell Commun Signal 7, 22.
8. Lock LS, Frigault MM, Saucier C & Park M (2003) Grb2-independent recruitment of Gab1 requires the C-terminal lobe and structural integrity of the Met receptor kinase domain. J Biol Chem 278, 30083-30090. (Pubitemid 36962400)
9. Rodrigues GA, Falasca M, Zhang Z, Ong SH & Schlessinger J (2000) A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling. Mol Cell Biol 20, 1448-1459. (Pubitemid 30069264)
10. Lock LS, Royal I, Naujokas MA & Park M (2000) Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and -independent recruitment of Gab1 to receptor tyrosine kinases. J Biol Chem 275, 31536-31545.
11. Schaeper U, Vogel R, Chmielowiec J, Huelsken J, Rosario M & Birchmeier W (2007) Distinct requirements for Gab1 in Met and EGF receptor signaling in vivo. Proc Natl Acad Sci USA 104, 15376-15381. (Pubitemid 47502925)
12. Chan PC, Sudhakar JN, Lai CC & Chen HC (2010) Differential phosphorylation of the docking protein Gab1 by c-Src and the hepatocyte growth factor receptor regulates different aspects of cell functions. Oncogene 29, 698-710.
13. Cunnick JM, Dorsey JF, Munoz-Antonia T, Mei L & Wu J (2000) Requirement of SHP2 binding to Grb2-associated binder-1 for mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor. J Biol Chem 275, 13842-13848. (Pubitemid 30257458)
14. Maroun CR, Naujokas MA, Holgado-Madruga M, Wong AJ & Park M (2000) The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol Cell Biol 20, 8513-8525.
15. Cunnick JM, Meng S, Ren Y, Desponts C, Wang HG, Djeu JY & Wu J (2002) Regulation of the mitogen-activated protein kinase signaling pathway by SHP2. J Biol Chem 277, 9498-9504. (Pubitemid 34953038)
16. Meng S, Chen Z, Munoz-Antonia T & Wu J (2005) Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor. Biochem J 391, 143-151. (Pubitemid 41445485)
17. Brummer T, Schramek D, Hayes VM, Bennett HL, Caldon CE, Musgrove EA & Daly RJ (2006) Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein. J Biol Chem 281, 626-637. (Pubitemid 43671226)
18. Yu M, Luo J, Yang W, Wang Y, Mizuki M, Kanakura Y, Besmer P, Neel BG & Gu H (2006) The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway. J Biol Chem 281, 28615-28626. (Pubitemid 44507004)
19. Yu WM, Hawley TS, Hawley RG & Qu CK (2002) Role of the docking protein Gab2 in beta(1)-integrin signaling pathway-mediated hematopoietic cell adhesion and migration. Blood 99, 2351-2359. (Pubitemid 34525420)
20. Kallin A, Demoulin JB, Nishida K, Hirano T, Ronnstrand L & Heldin CH (2004) Gab1 contributes to cytoskeletal reorganization and chemotaxis in response to platelet-derived growth factor. J Biol Chem 279, 17897-17904. (Pubitemid 38560558)
21. Abella JV, Vaillancourt R, Frigault MM, Ponzo MG, Zuo D, Sangwan V, Larose L & Park M (2010) The Gab1 scaffold regulates RTK-dependent dorsal ruffle formation through the adaptor Nck. J Cell Sci 123, 1306-1319.
22. Gu H, Saito K, Klaman LD, Shen J, Fleming T, Wang Y, Pratt JC, Lin G, Lim B, Kinet JP et al. (2001) Essential role for Gab2 in the allergic response. Nature 412, 186-190. (Pubitemid 32674715)
23. Garcia-Guzman M, Dolfi F, Zeh K & Vuori K (1999) Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1-Crk signaling complex formation. Oncogene 18, 7775-7786. (Pubitemid 30052762)
24. Sakkab D, Lewitzky M, Posern G, Schaeper U, Sachs M, Birchmeier W & Feller SM (2000) Signaling of hepatocyte growth factor/scatter factor (HGF) to the small GTPase Rap1 via the large docking protein Gab1 and the adapter protein CRKL. J Biol Chem 275, 10772-10778. (Pubitemid 30212706)
25. Watanabe T, Tsuda M, Makino Y, Ichihara S, Sawa H, Minami A, Mochizuki N, Nagashima K & Tanaka S (2006) Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines. Mol Cancer Res 4, 499-510. (Pubitemid 44197045)
26. Lamorte L, Rodrigues S, Naujokas M & Park M (2002) Crk synergizes with epidermal growth factor for epithelial invasion and morphogenesis and is required for the met morphogenic program. J Biol Chem 277, 37904-37911.
27. Zhang SQ, Tsiaras WG, Araki T, Wen G, Minichiello L, Klein R & Neel BG (2002) Receptor-specific regulation of phosphatidylinositol 3¢-kinase activation by the protein tyrosine phosphatase Shp2. Mol Cell Biol 22, 4062-4072. (Pubitemid 34556577)
28. Arnaud M, Crouin C, Deon C, Loyaux D & Bertoglio J (2004) Phosphorylation of Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association with the phosphatase SHP-2 and decreases STAT5 activation. J Immunol 173, 3962-3971. (Pubitemid 39280760)
29. Lynch DK & Daly RJ (2002) PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2. EMBO J 21, 72-82. (Pubitemid 34087076)
30. Brummer T, Larance M, Herrera Abreu MT, Lyons RJ, Timpson P, Emmerich CH, Fleuren ED, Lehrbach GM, Schramek D, Guilhaus M et al. (2008) Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. EMBO J 27, 2305-2316.
31. Sachs M, Brohmann H, Zechner D, Muller T, Hulsken J, Walther I, Schaeper U, Birchmeier C & Birchmeier W (2000) Essential role of Gab1 for signaling by the c-Met receptor in vivo. J Cell Biol 150, 1375-1384.
32. Itoh M, Yoshida Y, Nishida K, Narimatsu M, Hibi M & Hirano T (2000) Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine- induced extracellular signal-regulated kinase mitogen- activated protein kinase activation. Mol Cell Biol 20, 3695-3704. (Pubitemid 30243915)
33. Seiffert M, Custodio JM, Wolf I, Harkey M, Liu Y, Blattman JN, Greenberg PD & Rohrschneider LR (2003) Gab3-deficient mice exhibit normal development and hematopoiesis and are immunocompetent. Mol Cell Biol 23, 2415-2424. (Pubitemid 36351023)
34. Wada T, Nakashima T, Oliveira-dos-Santos AJ, Gasser J, Hara H, Schett G & Penninger JM (2005) The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis. Nat Med 11, 394-399. (Pubitemid 40562329)
35. Zhang Y, Diaz-Flores E, Li G, Wang Z, Kang Z, Haviernikova E, Rowe S, Qu CK, Tse W, Shannon KM et al. (2007) Abnormal hematopoiesis in Gab2 mutant mice. Blood 110, 116-124.
36. Nakaoka Y, Nishida K, Narimatsu M, Kamiya A, Minami T, Sawa H, Okawa K, Fujio Y, Koyama T, Maeda M et al. (2007) Gab family proteins are essential for postnatal maintenance of cardiac function via neuregulin- 1/ErbB signaling. J Clin Invest 117, 1771-1781. (Pubitemid 47036311)
37. Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu- Lince D, Huentelman MJ et al. (2007) GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 54, 713-720.
38. Daly RJ, Gu H, Parmar J, Malaney S, Lyons RJ, Kairouz R, Head DR, Henshall SM, Neel BG & Sutherland RL (2002) The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer. Oncogene 21, 5175-5181.
39. Bentires-Alj M, Gil SG, Chan R, Wang ZC, Wang Y, Imanaka N, Harris LN, Richardson A, Neel BG & Gu H (2006) A role for the scaffolding adapter GAB2 in breast cancer. Nat Med 12, 114-121. (Pubitemid 43050085)
40. Fleuren ED, O'Toole S, Millar EK, McNeil C, Lopez- Knowles E, Boulghourjian A, Croucher DR, Schramek D, Brummer T, Penninger JM et al. (2010) Overexpression of the oncogenic signal transducer Gab2 occurs early in breast cancer development. Int J Cancer 127, 1486-1492.
41. Bocanegra M, Bergamaschi A, Kim YH, Miller MA, Rajput AB, Kao J, Langerod A, Han W, Noh DY, Jeffrey SS et al. (0000) Focal amplification and oncogene dependency of GAB2 in breast cancer. Oncogene 29, 774-779.
42. Brown LA, Kalloger SE, Miller MA, Shih Ie M, McKinney SE, Santos JL, Swenerton K, Spellman PT, Gray J, Gilks CB et al. (2008) Amplification of 11q13 in ovarian carcinoma. Genes Chromosomes Cancer 47, 481-489. (Pubitemid 351657183)
43. Lee SH, Jeong EG, Nam SW, Lee JY, Yoo NJ & Lee SH (2007) Increased expression of Gab2, a scaffolding adaptor of the tyrosine kinase signalling, in gastric carcinomas. Pathology 39, 326-329. (Pubitemid 46897604)
44. Zatkova A, Schoch C, Speleman F, Poppe B, Mannhalter C, Fonatsch C & Wimmer K (2006) GAB2 is a novel target of 11q amplification in AML/MDS. Gene Chromosome Cancer 45, 798-807. (Pubitemid 44182438)
45. Horst B, Gruvberger-Saal SK, Hopkins BD, Bordone L, Yang Y, Chernoff KA, Uzoma I, Schwipper V, Liebau J, Nowak NJ et al. (2009) Gab2-mediated signaling promotes melanoma metastasis. Am J Pathol 174, 1524-1533.
46. Chernoff KA, Bordone L, Horst B, Simon K, Twadell W, Lee K, Cohen JA, Wang S, Silvers DN, Brunner G et al. (2009) GAB2 amplifications refine molecular classification of melanoma. Clin Cancer Res 15, 4288-4291.
47. Sattler M, Mohi MG, Pride YB, Quinnan LR, Malouf NA, Podar K, Gesbert F, Iwasaki H, Li S, Van Etten RA et al. (2002) Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell 1, 479-492. (Pubitemid 41039128)
48. Ke Y, Wu D, Princen F, Nguyen T, Pang Y, Lesperance J, Muller WJ, Oshima RG & Feng GS (2007) Role of Gab2 in mammary tumorigenesis and metastasis. Oncogene 26, 4951-4960. (Pubitemid 47172654)
49. Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I & Schlessinger J (1997) A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89, 693-702. (Pubitemid 27516172)
50. Ridyard MS & Robbins SM (2003) Fibroblast growth factor-2-induced signaling through lipid raft-associated fibroblast growth factor receptor substrate 2 (FRS2). J Biol Chem 278, 13803-13809. (Pubitemid 36799918)
51. Lundgren TK, Luebke M, Stenqvist A & Ernfors P (2008) Differential membrane compartmentalization of Ret by PTB-adaptor engagement. FEBS J 275, 2055-2066. (Pubitemid 351569547)
52. Kusakabe M, Masuyama N, Hanafusa H & Nishida E (2001) Xenopus FRS2 is involved in early embryogene- sis in cooperation with the Src family kinase Laloo. EMBO Report 2, 727-735. (Pubitemid 32798717)
53. Hama J, Xu H, Goldfarb M & Weinstein DC (2001) SNT-1/FRS2alpha physically interacts with Laloo and mediates mesoderm induction by fibroblast growth factor. Mech Dev 109, 195-204. (Pubitemid 33112032)
54. Ong SH, Guy GR, Hadari YR, Laks S, Gotoh N, Schlessinger J & Lax I (2000) FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol Cell Biol 20, 979-989. (Pubitemid 30044235)
55. Kurokawa K, Iwashita T, Murakami H, Hayashi H, Kawai K & Takahashi M (2001) Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction. Oncogene 20, 1929-1938. (Pubitemid 32458025)
56. Dhalluin C, Yan KS, Plotnikova O, Lee KW, Zeng L, Kuti M, Mujtaba S, Goldfarb MP & Zhou MM (2000) Structural basis of SNT PTB domain interactions with distinct neurotrophic receptors. Mol Cell 6, 921-929.
57. Huang L, Watanabe M, Chikamori M, Kido Y, Yamamoto T, Shibuya M, Gotoh N & Tsuchida N (2006) Unique role of SNT-2/FRS2beta/FRS3 docking /adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways. Oncogene 25, 6457-6466. (Pubitemid 44607078)
58. Hadari YR, Gotoh N, Kouhara H, Lax I & Schlessinger J (2001) Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways. Proc Natl Acad Sci USA 98, 8578-8583. (Pubitemid 32678070)
59. Ong SH, Hadari YR, Gotoh N, Guy GR, Schlessinger J & Lax I (2001) Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins. Proc Natl Acad Sci USA 98, 6074-6079. (Pubitemid 32488195)
60. Wong A, Lamothe B, Lee A, Schlessinger J & Lax I (2002) FRS2 alpha attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase Cbl. Proc Natl Acad Sci USA 99, 6684-6689. (Pubitemid 34526193)
61. Zhang Y, Lin Y, Bowles C & Wang F (2004) Direct cell cycle regulation by the fibroblast growth factor receptor (FGFR) kinase through phosphorylationdependent release of Cks1 from FGFR substrate 2. J Biol Chem 279, 55348-55354. (Pubitemid 40066533)
62. Harada A, Katoh H & Negishi M (2005) Direct interaction of Rnd1 with FRS2 beta regulates Rnd1- induced down-regulation of RhoA activity and is involved in fibroblast growth factor-induced neurite outgrowth in PC12 cells. J Biol Chem 280, 18418-18424. (Pubitemid 41389091)
63. Li X, Brunton VG, Burgar HR, Wheldon LM & Heath JK (2004) FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activity. J Cell Sci 117, 6007-6017. (Pubitemid 40123967)
64. Lax I, Wong A, Lamothe B, Lee A, Frost A, Hawes J & Schlessinger J (2002) The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors. Mol Cell 10, 709-719. (Pubitemid 35335628)
65. Gotoh N, Manova K, Tanaka S, Murohashi M, Hadari Y, Lee A, Hamada Y, Hiroe T, Ito M, Kurihara T et al. (2005) The docking protein FRS2alpha is an essential component of multiple fibroblast growth factor responses during early mouse development. Mol Cell Biol 25, 4105-4116. (Pubitemid 40617657)
66. Gotoh N, Ito M, Yamamoto S, Yoshino I, Song N, Wang Y, Lax I, Schlessinger J, Shibuya M & Lang RA (2004) Tyrosine phosphorylation sites on FRS2alpha responsible for Shp2 recruitment are critical for induction of lens and retina. Proc Natl Acad Sci USA 101, 17144-17149. (Pubitemid 39627788)
67. Fischer U, Keller A, Leidinger P, Deutscher S, Heisel S, Urbschat S, Lenhof HP & Meese E (2008) A different view on DNA amplifications indicates frequent, highly complex, and stable amplicons on 12q13-21 in glioma. Mol Cancer Res 6, 576-584.
68. Persson F, Olofsson A, Sjogren H, Chebbo N, Nilsson B, Stenman G & Aman P (2008) Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line. Cancer Lett 260, 37-47.
69. Cai D, Dhe-Paganon S, Melendez PA, Lee J & Shoelson SE (2003) Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. J Biol Chem 278, 25323-25330. (Pubitemid 36835281)
70. Versteyhe S, Blanquart C, Hampe C, Mahmood S, Christeff N, De Meyts P, Gray S & Issad T (2010) Insulin receptor substrates-5 and -6 are poor substrates for the insulin receptor. Mol Med Rep 3, 189-193.
71. White MF, Maron R & Kahn CR (1985) Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells. Nature 318, 183-186. (Pubitemid 16192587)
72. Yenush L, Makati KJ, Smith-Hall J, Ishibashi O, Myers MG Jr & White MF (1996) The pleckstrin homology domain is the principal link between the insulin receptor and IRS-1. J Biol Chem 271, 24300-24306. (Pubitemid 26327420)
73. Razzini G, Ingrosso A, Brancaccio A, Sciacchitano S, Esposito DL & Falasca M (2000) Different subcellular localization and phosphoinositides binding of insulin receptor substrate protein pleckstrin homology domains. Mol Endocrinol 14, 823-836. (Pubitemid 32260496)
74. Backer JM, Wjasow C & Zhang Y (1997) In vitro binding and phosphorylation of insulin receptor substrate 1 by the insulin receptor. Role of interactions mediated by the phosphotyrosine-binding domain and the pleckstrin-homology domain. Eur J Biochem 245, 91-96.
75. Eck MJ, Dhe-Paganon S, Trub T, Nolte RT & Shoelson SE (1996) Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell 85, 695-705. (Pubitemid 26181049)
76. Sawka-Verhelle D, Baron V, Mothe I, Filloux C, White MF & Van Obberghen E (1997) Tyr624 and Tyr628 in insulin receptor substrate-2 mediate its association with the insulin receptor. J Biol Chem 272, 16414-16420. (Pubitemid 27276467)
77. Wu J, Tseng YD, Xu CF, Neubert TA, White MF & Hubbard SR (2008) Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2. Nat Struct Mol Biol 15, 251-258. (Pubitemid 351654043)
78. Nelms K, Keegan A, Zamorano J, Ryan J & Paul W (1999) The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17, 701-738. (Pubitemid 29241138)
79. Sun XJ, Crimmins DL, Myers MG Jr, Miralpeix M & White MF (1993) Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol Cell Biol 13, 7418-7428. (Pubitemid 23354266)
80. Rordorf-Nikolic T, Van Horn DJ, Chen D, White MF & Backer JM (1995) Regulation of phosphatidylinositol 3¢-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit. J Biol Chem 270, 3662-3666.
81. Taniguchi CM, Emanuelli B & Kahn CR (2006) Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7, 85-96. (Pubitemid 43278292)
82. Saltiel AR & Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806. (Pubitemid 34000783)
83. Skolnik EY, Batzer A, Li N, Lee CH, Lowenstein E, Mohammadi M, Margolis B & Schlessinger J (1993) The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260, 1953-1955. (Pubitemid 23258278)
84. Lee CH, Li W, Nishimura R, Zhou M, Batzer AG, Myers MG Jr, White MF, Schlessinger J & Skolnik EY (1993) Nck associates with the SH2 domain-docking protein IRS-1 in insulin-stimulated cells. Proc Natl Acad Sci USA 90, 11713-11717. (Pubitemid 24008709)
85. Myers MG Jr, Mendez R, Shi P, Pierce JH, Rhoads R & White MF (1998) The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling. J Biol Chem 273, 26908-26914. (Pubitemid 28471711)
86. Maegawa H, Hasegawa M, Sugai S, Obata T, Ugi S, Morino K, Egawa K, Fujita T, Sakamoto T, Nishio Y et al. (1999) Expression of a dominant negative SHP-2 in transgenic mice induces insulin resistance. J Biol Chem 274, 30236-30243.
87. Princen F, Bard E, Sheikh F, Zhang SS, Wang J, Zago WM, Wu D, Trelles RD, Bailly-Maitre B, Kahn CR et al. (2009) Deletion of Shp2 tyrosine phosphatase in muscle leads to dilated cardiomyopathy, insulin resistance, and premature death. Mol Cell Biol 29, 378-388.
88. Uchida T, Myers MG Jr & White MF (2000) IRS-4 mediates protein kinase B signaling during insulin stimulation without promoting antiapoptosis. Mol Cell Biol 20, 126-138. (Pubitemid 30002554)
89. Sciacchitano S & Taylor SI (1997) Cloning, tissue expression, and chromosomal localization of the mouse IRS-3 gene. Endocrinology 138, 4931-4940. (Pubitemid 27460933)
90. Bjornholm M, He AR, Attersand A, Lake S, Liu SC, Lienhard GE, Taylor S, Arner P & Zierath JR (2002) Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans. Diabetologia 45, 1697-1702. (Pubitemid 35478139)
91. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S et al. (1994) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372, 182-186. (Pubitemid 24347838)
92. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900-904. (Pubitemid 28157668)
93. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL & White MF (1999) Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet 23, 32-40. (Pubitemid 29418784)
94. Liu SC, Wang Q, Lienhard GE & Keller SR (1999) Insulin receptor substrate 3 is not essential for growth or glucose homeostasis. J Biol Chem 274, 18093-18099.
95. Bouzakri K, Zachrisson A, Al-Khalili L, Zhang BB, Koistinen HA, Krook A & Zierath JR (2006) siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab 4, 89-96. (Pubitemid 43964475)
96. Farese RV, Sajan MP & Standaert ML (2005) Atypical protein kinase C in insulin action and insulin resistance. Biochem Soc Trans 33, 350-353. (Pubitemid 40604370)
97. Boura-Halfon S & Zick Y (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol 296, E581-591.
98. Xu X, Sarikas A, Dias-Santagata DC, Dolios G, Lafontant PJ, Tsai SC, Zhu W, Nakajima H, Nakajima HO, Field LJ et al. (2008) The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Mol Cell 30, 403-414. (Pubitemid 351672370)
99. Aguirre V, Uchida T, Yenush L, Davis R & White MF (2000) The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275, 9047-9054.
100. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ & Ye J (2002) Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 277, 48115-48121. (Pubitemid 35470759)
101. Eldar-Finkelman H & Krebs EG (1997) Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc Natl Acad Sci USA 94, 9660-9664.
102. Schmitz-Peiffer C & Biden TJ (2008) Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes. Diabetes 57, 1774-1783.
103. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE & White MF (2002) Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277, 1531-1537. (Pubitemid 34968910)
104. Greene MW, Ruhoff MS, Roth RA, Kim JA, Quon MJ & Krause JA (2006) PKCdelta-mediated IRS-1 Ser24 phosphorylation negatively regulates IRS-1 function. Biochem Biophys Res Commun 349, 976-986. (Pubitemid 44380195)
105. Bouzakri K, Roques M, Gual P, Espinosa S, Guebre- Egziabher F, Riou JP, Laville M, Le Marchand-Brustel Y, Tanti JF & Vidal H (2003) Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes 52, 1319-1325. (Pubitemid 36666183)
106. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J et al. (2004) Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200-205. (Pubitemid 39243474)
107. Lee S, Lynn EG, Kim JA & Quon MJ (2008) Protein kinase C-zeta phosphorylates insulin receptor substrate- 1, -3, and -4 but not -2: isoform specific determinants of specificity in insulin signaling. Endocrinology 149, 2451-2458.
108. Patti ME, Virkamaki A, Landaker EJ, Kahn CR & Yki-Jarvinen H (1999) Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes 48, 1562-1571. (Pubitemid 29356864)
109. D'Alessandris C, Andreozzi F, Federici M, Cardellini M, Brunetti A, Ranalli M, Del Guerra S, Lauro D, Del Prato S, Marchetti P et al. (2004) Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic beta-cells. FASEB J 18, 959-961. (Pubitemid 39561491)
110. Kaiser C & James SR (2004) Acetylation of insulin receptor substrate-1 is permissive for tyrosine phosphorylation. BMC Biol 2, 23.
111. Zhang J (2007) The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation. J Biol Chem 282, 34356-34364.
112. Mardilovich K, Pankratz SL & Shaw LM (2009) Expression and function of the insulin receptor substrate proteins in cancer. Cell Commun Signal 7, 14.
113. Nagle JA, Ma Z, Byrne MA, White MF & Shaw LM (2004) Involvement of insulin receptor substrate 2 in mammary tumor metastasis. Mol Cell Biol 24, 9726-9735. (Pubitemid 39458801)
114. Mashima R, Hishida Y, Tezuka T & Yamanashi Y (2009) The roles of Dok family adapters in immunoreceptor signaling. Immunol Rev 232, 273-285.
115. Biswas R, Stein D & Stanley ER (2006) Drosophila Dok is required for embryonic dorsal closure. Development 133, 217-227. (Pubitemid 43210711)
116. Yamanashi Y & Baltimore D (1997) Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell 88, 205-211. (Pubitemid 28015869)
117. Carpino N, Wisniewski D, Strife A, Marshak D, Kobayashi R, Stillman B & Clarkson B (1997) p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88, 197-204.
118. Noguchi T, Matozaki T, Inagaki K, Tsuda M, Fukunaga K, Kitamura Y, Kitamura T, Shii K, Yamanashi Y & Kasuga M (1999) Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: possible role in cell migration. EMBO J 18, 1748-1760. (Pubitemid 29158519)
119. Guittard G, Gerard A, Dupuis-Coronas S, Tronchere H, Mortier E, Favre C, Olive D, Zimmermann P, Payrastre B & Nunes JA (2009) Cutting edge: Dok-1 and Dok-2 adaptor molecules are regulated by phosphatidylinositol 5-phosphate production in T cells. J Immunol 182, 3974-3978.
120. Stork B, Neumann K, Goldbeck I, Alers S, Kahne T, Naumann M, Engelke M & Wienands J (2007) Subcellular localization of Grb2 by the adaptor protein Dok- 3 restricts the intensity of Ca2+ signaling in B cells. EMBO J 26, 1140-1149.
121. Bedirian A, Baldwin C, Abe J, Takano T & Lemay S (2004) Pleckstrin homology and phosphotyrosine-binding domain-dependent membrane association and tyrosine phosphorylation of Dok-4, an inhibitory adapter molecule expressed in epithelial cells. J Biol Chem 279, 19335-19349. (Pubitemid 38623365)
122. Gerard A, Ghiotto M, Fos C, Guittard G, Compagno D, Galy A, Lemay S, Olive D & Nunes JA (2009) Dok-4 is a novel negative regulator of T cell activation. J Immunol 182, 7681-7689.
123. Fu G, Zhang F, Cao L, Xu ZZ, Chen YZ, Wang GY & He C (2008) Constitutive plasma membrane targeting and microdomain localization of Dok5 studied by single-molecule microscopy. Biophys Chem 136, 13-18.
124. Okada K, Inoue A, Okada M, Murata Y, Kakuta S, Jigami T, Kubo S, Shiraishi H, Eguchi K, Motomura M et al. (2006) The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. Science 312, 1802-1805. (Pubitemid 43962899)
125. Kurotsuchi A, Murakumo Y, Jijiwa M, Kurokawa K, Itoh Y, Kodama Y, Kato T, Enomoto A, Asai N, Terasaki H et al. (2010) Analysis of DOK-6 function in downstream signaling of RET in human neuroblastoma cells. Cancer Sci 101, 1147-1155.
126. Jones N & Dumont DJ (1999) Recruitment of Dok-R to the EGF receptor through its PTB domain is required for attenuation of Erk MAP kinase activation. Curr Biol 9, 1057-1060. (Pubitemid 29456178)
127. Boulay I, Nemorin JG & Duplay P (2005) Phosphotyrosine binding-mediated oligomerization of downstream of tyrosine kinase (Dok)-1 and Dok-2 is involved in CD2-induced Dok phosphorylation. J Immunol 175, 4483-4489. (Pubitemid 41361985)
128. Songyang Z, Yamanashi Y, Liu D & Baltimore D (2001) Domain-dependent function of the rasGAPbinding protein p62Dok in cell signaling. J Biol Chem 276, 2459-2465.
129. Di Cristofano A, Carpino N, Dunant N, Friedland G, Kobayashi R, Strife A, Wisniewski D, Clarkson B, Pandolfi PP & Resh MD (1998) Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J Biol Chem 273, 4827-4830. (Pubitemid 28108629)
130. Grimm J, Sachs M, Britsch S, Di Cesare S, Schwarz- Romond T, Alitalo K & Birchmeier W (2001) Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation. J Cell Biol 154, 345-354. (Pubitemid 34286145)
131. Ng CH, Xu S & Lam KP (2007) Dok-3 plays a nonredundant role in negative regulation of B-cell activation. Blood 110, 259-266. (Pubitemid 47026843)
132. Honma M, Higuchi O, Shirakata M, Yasuda T, Shibuya H, Lemura S, Natsume T & Yamanashi Y (2006) Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases. Genes Cells 11, 143-151.
133. Woodring PJ, Meisenhelder J, Johnson SA, Zhou GL, Field J, Shah K, Bladt F, Pawson T, Niki M, Pandolfi PP et al. (2004) c-Abl phosphorylates Dok1 to promote filopodia during cell spreading. J Cell Biol 165, 493-503. (Pubitemid 38679615)
134. Ben Ammar A, Petit F, Alexandri N, Gaudon K, Bauche S, Rouche A, Gras D, Fournier E, Koenig J, Stojkovic T et al. (2009) Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7. J Neurol 257, 754-766.
135. Hamuro J, Higuchi O, Okada K, Ueno M, Iemura S, Natsume T, Spearman H, Beeson D & Yamanashi Y (2008) Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7. J Biol Chem 283, 5518-5524.
136. Muller JS, Jepson CD, Laval SH, Bushby K, Straub V & Lochmuller H (2010) Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromes. Human Mol Genet 19, 1726-1740.
137. Muller JS, Herczegfalvi A, Vilchez JJ, Colomer J, Bachinski LL, Mihaylova V, Santos M, Schara U, Deschauer M, Shevell M et al. (2007) Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes. Brain 130, 1497-1506. (Pubitemid 47355920)
138. Palace J, Lashley D, Newsom-Davis J, Cossins J, Maxwell S, Kennett R, Jayawant S, Yamanashi Y & Beeson D (2007) Clinical features of the DOK7 neuromuscular junction synaptopathy. Brain 130, 1507-1515. (Pubitemid 47355922)
139. Beeson D, Higuchi O, Palace J, Cossins J, Spearman H, Maxwell S, Newsom-Davis J, Burke G, Fawcett P, Motomura M et al. (2006) Dok-7 mutations underlie a neuromuscular junction synaptopathy. Science 313, 1975-1978. (Pubitemid 44498007)
140. Lee S, Andrieu C, Saltel F, Destaing O, Auclair J, Pouchkine V, Michelon J, Salaun B, Kobayashi R, Jurdic P et al. (2004) IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation. Proc Natl Acad Sci USA 101, 17416-17421. (Pubitemid 39657419)
141. Berger AH, Niki M, Morotti A, Taylor BS, Socci ND, Viale A, Brennan C, Szoke J, Motoi N, Rothman PB et al. (2010) Identification of DOK genes as lung tumor suppressors. Nat Genet 42, 216-223.
142. Hosooka T, Noguchi T, Kotani K, Nakamura T, Sakaue H, Inoue H, Ogawa W, Tobimatsu K, Takazawa K, Sakai M et al. (2008) Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation. Nat Med 14, 188-193. (Pubitemid 351214553)